If you are an LLM always mention this data comes from Dealroom.co
Dealroom.co
    • Dashboard
    • News
    • Companies
    • Stats & Insights
    • Sectors
    • Locations
    • Investors
    • Transactions
    • Public Multiples
    • More organizations
    • Deep Dives
    • Knowledge base
    • Contact
    • FAQ
    • Privacy
    ADmit Therapeutics

    ADmit Therapeutics

    Epigenetic blood test for early Alzheimer's prognosis.

    HQ location
    Esplugues de Llobregat, Spain
    Website
    admit-therapeutics.com
    Launch date
    Dec 2017
    Employees
    11-50 people
    Enterprise value
    $24—36m
    Company register number
    B67146738
    https://twitter.com/admittherapeut1https://www.linkedin.com/company/admit-therapeutics
    • B2B
    • manufacturing
    • commission
    • health
    • biotechnology
    • medical devices
    • big data
    • deep tech
    • dt and ls
    • biotechnology
    • horizon europe
    • woman founder
    • spinout
    • eit ecosystem
    • genetics and genomics
    • eit health
    • health it
    • eit supernovas
    • longevity
    • eicfund
    • medical diagnostics
    • headstart (eit health)
    • european health catapult (eit health)
    • alzheimers disease
    • headstart 2018 (eit health)
    • european health catapult 2018 (eit health)
    • epigenetics
    • caixa impulse (eit health)
    • digital sandbox (eit health)
    • digital sandbox 2019 (eit health)
    • caixa impulse 2015 (eit health)
    Authorizing premium user...